Novo Nordisk - ADR XNYS: NVO

Novo Nordisk - ADR Live Stock Price Today, Share Analysis and Chart

Name: Novo Nordisk - ADR: Is Infosys Ltd. worth buying?
Item: Novo Nordisk - ADR
Rating: 2.108291625
Author: Trendlyne DVM scores

Slowing Down Stock

about

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, inject...

49.46 -0.58 (-1.16%)

56.04% Fall from 52W High

20.0M

XNYS Volume

XNYS 31 Oct, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Novo Nordisk - ADR is on 07 Nov 2025 for the purpose of Novo Nordisk A/S Third Quarter Earnings Conference Call for 2025 See details

Medium Financial Strength

50.0 / 100

Mid Valuation

38.3 / 100

Technically Bearish

30.3 / 100

Slowing Down Stock These stocks score good in Quality and also have medium range financials. However, a bad technical scoring and bearish aspects decrease the investor's interest over time. View Similar Embed DVM

1Yr Price target upside is 21%

9 analysts

Novo Nordisk ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..